4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001193125-26-253929
Options or other derivatives
- General Counsel and Secretary acquired 17,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KASINGER JAMES R. · General Counsel and Secretary
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-29 | Grant or award : show line 1 in the form Restricted Stock Units | +17,000 | 17,000 | D |
Loading xslF345X06/ownership.xml…